The doctor will know if you're not taking your meds now

FDA approves the first pill that can alert your doctor when you swallow it

The tiny sensor used in the new pill was first approved by the FDA in 2012 and has since been available for pharmacies to place inside a capsule along with other medications.

Before we have all the answers to those questions, Abilify MyCite is expected to hit the market sometime next year, and for better or worse, the seeds of snitch medication will have been planted. The drug will help doctors in monitoring if their patients are taking their medicines on time.

The treatment, called Abilify MyCite, is essentially a clever delivery system for the antipsychotic aripiprazole, used to treat schizophrenia and bipolar disorder.

The technology is the product of research between Japanese pharmaceutical company Otsuka and Proteus Digital Health, and is created to solve the problem of people missing medicine doses, which costs the US healthcare system an estimated $200 billion per year. The medicine contains a "boxed warning" that cautions health care professionals about using the drug for patients who have dementia-related psychosis.

For the most part, developing new medical technologies is a huge benefit to people. Proteus Digital Health, based in Redwood City California, makes the sensor. The sensor, which has no battery or antenna, is activated when it gets wet from the fluids in the stomach, according to Reuters.

Moscow drafts 'reciprocal measures' over United States demands on Russia Today
The Duma is obliged to give its laws two preliminary approvals before passing them, which Volodin said could happen next week. Simonyan said that RT will comply, otherwise she could be arrested and the news outlet's accounts frozen.

Sheep can recognise human faces
During one set of trials, they were made to discern between their handler (whose photo they'd never seen before) and a new face. The sheep were less successful at identifying the tilted celebrities but still performed better than chance.

Netflix email scam targets millions of users
You can do this by hovering over the sender's name, though some email clients will display the actual address as well. Mailguard , a company that protects businesses against scammers and phishers took a screenshot of the email scam .

In a historic move by the US Food and Drug Administration (FDA), the first ever digital pill has been approved for use.

Patients wear a patch over their torso, which relays a signal between the drug pill and the mobile app.

The technology carries risks for patient privacy too if there are breaches of medical data or unauthorized use as a surveillance tool, said James Giordano, a professor of neurology at Georgetown University Medical Center. "Our rollout of the Abilify MyCite system will be done in phases to obtain, and respond to, feedback from healthcare providers and their patients". The agency also noted that the product has not shown an ability to improve patient compliance with a treatment regimen. FDA said in the clinical trials for Abilify, the most common side effects reported by adults taking Abilify were nausea, vomiting, constipation, headache, dizziness, uncontrollable limb and body movements, anxiety, insomnia, and restlessness.

The medicine, however, is not used to treat patients who suffer from psychosis related to dementia. In Abilify MyCite, skin irritation at the site of the MyCite patch may also occur. The chronic and severe mental disorder can cause hallucinations, disordered thinking, and delusions, such as hearing voices and believing that other people are reading their minds or spying on them. It's also been approved as a supplemental treatment for adult depression.